Probiotics and inflammatory bowel diseases

American Journal of Gastroenterology

Volumn 95, Issue 1 SUPPL., 2000, Pages

  Schultz, Michael ^a   Sartor, R Balfour ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMIPENEM; LACTULOSE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PROBIOTIC AGENT; VANCOMYCIN;

BIFIDOBACTERIUM; CONFERENCE PAPER; CROHN DISEASE; DIARRHEA; ENTERITIS; HUMAN; ILEITIS; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES; ULCERATIVE COLITIS;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; LACTOBACILLUS; PROBIOTICS;

EID: 0033970999     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00812-6     Document Type: Conference Paper

References (24)

1. Schultz M., Sartor R.B. Aberrant host immune responses to luminal bacteria in the pathogenesis of chronic inflammatory bowel disease. Ernst P.B., Michetti P., Smith P.D. The immunobiology of H. 1997;167-182 From pathogenesis to prevention. Philadelphia: Lippincott-Raven Publishers, pylori.
2. Bengmark S. Probiotics and prebiotics in prevention and treatment of gastrointestinal diseases. Gastroenterol Internat. 11:(suppl 1):1998;4-7.
3. Giaffer M.H., Holdsworth C.D., Duerden B.I. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol. 35:1991;238-243.
4. Rath H.C., Herfarth H.H., Ikeda J.S., et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 98:1996;945-953.
5. Rath H.C., Schultz M., Dieleman L.A., et al. Selective vs. broad spectrum antibiotics in the prevention and treatment of experimental colitis in two rodent models. Gastroenterology. 114:1998;A4367.
6. Sellon R.K., Tonkonogy S., Schultz M., et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 66:1998;5224-5231.
7. Sadlack B., Merz H., Schorle H., et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2-gen. Cell. 75:1993;253-261.
8. Schultz M., Tonkonogy S.L., Sellon R.K., et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol. 276:1999;G1461-G1472.
9. Metchnikoff E. The prolongation of life. Optimistic studies. 1907;William Heinemann, London.
10. Mack D. Unpublished observations, 1998.
11. Isolauri E., Marjamaa H., Arvola T., et al. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology. 105:1993;1643-1650.
12. Malin M., Suomalainen H., Saxelin M., et al. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab. 40:1996;137-145.
13. Offenbartl K., Bengmark S. Intra-abdominal infection and gut origin sepsis. World J Surg. 14:1990;191-195.
14. Mattila-Sandholm T., Salminen S. Up-to-date on probiotics in Europe. Gastroenterol Internat. 11:(suppl 1):1998;8-16.
15. Biller J.A., Katz A.J., Flores A.F., et al. Treatment of C. difficile colitis with Lactobacillus GG. J Ped Gastroenterol Nutr. 21:1995;224-226.
16. Oksanen P., Salminen S., Saxelin M., et al. Prevention of traveller's diarrhea by Lactobacillus GG. Ann Med. 22:1990;53-56.
17. Hilton E., Kolakowski P., Smith M., et al. Efficacy of Lactobacillus GG as a diarrheal preventative in travelers diarrhea. J Travel Med. 4:1996;41-43.
18. Kim P.H., Ko E.J. Bifidobacterium is a strong stimulant for IgA antibody production by mucosal B lymphocytes. FASEB J. 12:1998;A5278.
19. Kruis W., Schutz E., Fric P., et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 11:1997;853-858.
20. Gionchetti P., Rizzello F., Venturi A., et al. Maintenance therapy of chronic pouchitis A randomized, placebo-controlled, double blind trial with a new probiotic preparation . Gastroenterology. 114:1998;A4037.
21. Gionchetti P., Rizzello F., Matteuzzi D., et al. Microflora in the IBD pathogenesis. Possible therapeutic use of probiotics. Gastroenterol Internat. 11:1998;108-110.
22. Madsen K.L., Tavenini M.M., Doyle J.S.G., et al. Interleukin-10 gene deficient mice demonstrate a primary defect in IgA secretion. Gastroenterology. 112:1997;A1031.
23. Madsen K.L., Taverini M.M., Doyle J.S.G., et al. Lactobacillus sp. prevents development of enterocolitis in interleukin-10 gene deficient mice. Gastroenterology. 112:1997;A1030.
24. Schultz M., Veltkamp C., Dieleman L.A., et al. Continuous feeding of Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient mice. Gastroenterology. 114:1998;A4426.